Peptide transport activity of the transporter associated with antigen processing (TAP) is inhibited by an early protein of equine herpesvirus-1

Journal of General Virology

Volumn 85, Issue 2, 2004, Pages 349-353

  Ambagala, Aruna P N ^a   Gopinath, Raju S ^a   Srikumaran, S ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EQUINE HERPES VIRUS; EXPERIMENTATION; GENE TRANSLOCATION; HERPES SIMPLEX; IN VITRO STUDY; MATURATION; METABOLIC INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; DOWN-REGULATION; ENDOPLASMIC RETICULUM; HERPESVIRUS 1, EQUID; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMEDIATE-EARLY PROTEINS; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS;

EQUIDAE; EQUINE HERPESVIRUS 1; HERPESVIRIDAE;

EID: 1342289069     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19563-0     Document Type: Article

References (26)

1. Allen, G. P. & Bryans, J. T. (1986). Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Microbiol Immunol 2, 78-144.
2. Allen, G., Yeargan, M., Costa, L. R. & Cross, R. (1995). Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J Virol 69, 606-612.
3. Ambagala, A. P., Hinkley, S. & Srikumaran, S. (2000). An early pseudorabies virus protein down-regulates porcine MHC class I expression by inhibition of transporter associated with antigen processing (TAP). J Immunol 164, 93-99.
4. Bryans, J. T. (1981). Application of management procedures and prophylactic immunization to the control of equine rhinopneuminitis. Proc Am Assoc Equine Pract 26, 259-272.
5. Bryans, J. T. & Allen, G. P. (1989). Herpesvirus diseases of the horse. In Herpesvirus Diseases of Cattle, Horses and Pigs, pp. 176-229. Edited by G. Wittmann. Boston: Kluwer.
6. Burki, F., Rossmanith, W., Nowotny, N., Pallan, C., Mostl, K. & Lussy, H. (1990). Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet Q 12, 80-86.
7. Doll, E. R. & Bryans, J. T. (1963). Immunization of young horses against viral rhinopneumonitis. Cornell Vet 53, 24-41.
8. Edington, N., Bridges, C. G. & Huckle, A. (1985). Experimental reactivation of equid herpesvirus 1 (EHV 1) following the administration of corticosteroids. Equine Vet J 17, 369-372.
9. Feng, X., Thompson, Y. G., Lewis, J. B. & Caughman, G. B. (1996). Expression and function of the equine herpesvirus 1 virion-associated host shutoff homolog. J Virol 70, 8710-8718.
10. Gentry, M. J. & Srikumaran, S. (1991). Neutralizing monoclonal antibodies to Pasteurella haemolytica leukotoxin affinity-purify the toxin from crude culture supernatants. Microb Pathog 10, 411-417.
11. Gibson, J. S., Slater, J. D., Awan, A. R. & Field, H. J. (1992). Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Arch Virol 123, 351-366.
12. Hannant, D., O'Neill, T., Ostlund, E. N., Kydd, J. H., Hopkin, P. J. & Mumford, J. A. (1999). Equid herpesvirus-induced immunosuppression is associated with lymphoid cells and not soluble circulating factors. Viral Immunol 12, 313-321.
13. Hengel, H., Koopmann, J. O., Flohr, T., Muranyi, W., Goulmy, E., Hammerling, G. J., Koszinowski, U. H. & Momburg, F. (1997). A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6, 623-632.
14. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H. & Johnson, D. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.
15. Hinkley, S., Hill, A. B. & Srikumaran, S. (1998). Bovine herpesvirus-1 infection affects the peptide transport activity in bovine cells. Virus Res 53, 91-96.
16. Koppers-Lalic, D., Rijsewijk F. A., Verschuren, S. B., van Gaans-van den Brink, J. A., Neisig, A., Ressing, M. E., Neefjes, J. & Wiertz, E. J. (2001). The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1. J Gen Virol 82, 2071-2081.
17. Lehner, P. J., Karttunen, J. T., Wilkinson, G. W. & Cresswell, P. (1997). The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A 94, 6904-6909.
18. + cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J Virol 68, 1459-1467.
19. Martens, J. G. & Martens, R. J. (1991). Equine herpesvirus type 1: its classification, pathogenesis and prevention. Vet Med 86, 936-940.
20. Mumford, J. A., Rossdale, P. D., Jessett, D. M., Gann, S. J., Ousey, J. & Cook, R. F. (1987). Serological and virological investigations of an equid herpesvirus 1 (EHV-1) abortion storm on a stud farm in 1985. J Reprod Fertil 35, 509-518.
21. Neefjes, J. J., Momburg, F. & Hammerling, G. J. (1993). Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261, 769-771.
22. Rappocciolo, G., Birch, J. & Ellis, S. A. (2003). Down-regulation of MHC class I expression by equine herpesvirus-1. J Gen Virol 84, 293-300.
23. Tomazin, R., Hill, A. B., Jugovic, P., York, I., Van Endert, P., Ploegh, H. L., Andrews, D. W. & Johnson, D. C. (1996). Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15, 3256-3266.
24. van der Meulen, K. M., Nauwynck, H. J. & Pensaert, M. B. (2003). Absence of viral antigens on the surface of equine herpesvirus-1-infected peripheral blood mononuclear cells: a strategy to avoid complement-mediated lysis. J Gen Virol 84, 93-97.
25. Vossen, M. T., Westerhout, E. M., Soderberg-Naucler, C. & Wiertz, E. J. (2002). Viral immune evasion: a masterpiece of evolution. Immunogenetics 54, 527-542.
26. Williams, A., Peh, C. A. & Elliott, T. (2002). The cell biology of MHC class I antigen presentation. Tissue Antigens 59, 3-17.